Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The pharma possibility...

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Jun 15, 2024 4:04pm

171 Views

Post# 36090696

RE:RE:RE:RE:RE:The pharma possibility...

For that reaso, I suspect that On a very short window pp like this they would probably ask approval for a bit more than what they might already have significant interest for. Frankly I'd much prefer they only did 5 or 6 rather than the full allotment. (Partly because of the size block it would be if it were a single entity taking it.)

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement